News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
626,217 Results
Type
Article (43305)
Company Profile (243)
Press Release (582649)
Multimedia
Podcasts (119)
Webinars (22)
Section
Business (176821)
Career Advice (2506)
Deals (32430)
Drug Delivery (121)
Drug Development (76198)
Employer Resources (161)
FDA (14902)
Job Trends (14533)
News (308569)
Policy (30691)
Tag
Academia (2672)
Academic (1)
Accelerated approval (14)
Adcomms (30)
Allergies (106)
Alliances (46519)
ALS (130)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (179)
Approvals (14943)
Artificial intelligence (374)
Autoimmune disease (45)
Automation (20)
Bankruptcy (324)
Best Places to Work (11035)
BIOSECURE Act (22)
Biosimilars (138)
Biotechnology (133)
Bladder cancer (109)
Brain cancer (40)
Breast cancer (382)
Cancer (3173)
Cardiovascular disease (281)
Career advice (2089)
Career pathing (33)
CAR-T (203)
CDC (40)
Cell therapy (530)
Cervical cancer (27)
Clinical research (63551)
Collaboration (1161)
Company closure (1)
Compensation (479)
Complete response letters (47)
COVID-19 (2574)
CRISPR (77)
C-suite (458)
Cystic fibrosis (113)
Data (3476)
Decentralized trials (2)
Denatured (36)
Depression (85)
Diabetes (356)
Diagnostics (5703)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (171)
Drug pricing (159)
Drug shortages (34)
Duchenne muscular dystrophy (166)
Earnings (67885)
Editorial (50)
Employer branding (18)
Employer resources (143)
Events (92043)
Executive appointments (884)
FDA (16987)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (996)
Gene editing (158)
Generative AI (31)
Gene therapy (427)
GLP-1 (898)
Government (4605)
Grass and pollen (6)
Guidances (325)
Healthcare (17196)
HIV (42)
Huntington's disease (30)
IgA nephropathy (52)
Immunology and inflammation (192)
Immuno-oncology (15)
Indications (43)
Infectious disease (2769)
Inflammatory bowel disease (165)
Inflation Reduction Act (10)
Influenza (73)
Intellectual property (150)
Interviews (424)
IPO (14432)
IRA (55)
Job creations (3871)
Job search strategy (1750)
Kidney cancer (12)
Labor market (58)
Layoffs (529)
Leadership (30)
Legal (6955)
Liver cancer (79)
Longevity (10)
Lung cancer (458)
Lymphoma (239)
Machine learning (19)
Management (59)
Manufacturing (506)
MASH (107)
Medical device (11119)
Medtech (11135)
Mergers & acquisitions (18753)
Metabolic disorders (951)
Multiple sclerosis (112)
NASH (22)
Neurodegenerative disease (154)
Neuropsychiatric disorders (44)
Neuroscience (2252)
NextGen: Class of 2025 (6221)
Non-profit (4539)
Now hiring (50)
Obesity (491)
Opinion (287)
Ovarian cancer (110)
Pain (147)
Pancreatic cancer (133)
Parkinson's disease (193)
Partnered (21)
Patents (354)
Patient recruitment (242)
Peanut (50)
People (54128)
Pharmaceutical (95)
Pharmacy benefit managers (25)
Phase I (19685)
Phase II (27879)
Phase III (21306)
Pipeline (2329)
Policy (263)
Postmarket research (2218)
Preclinical (8025)
Press Release (70)
Prostate cancer (156)
Psychedelics (38)
Radiopharmaceuticals (249)
Rare diseases (528)
Real estate (5696)
Recruiting (63)
Regulatory (22105)
Reports (44)
Research institute (2345)
Resumes & cover letters (439)
Rett syndrome (9)
RNA editing (12)
RSV (60)
Schizophrenia (113)
Series A (167)
Series B (125)
Service/supplier (12)
Sickle cell disease (75)
Special edition (22)
Spinal muscular atrophy (145)
Sponsored (36)
Startups (3432)
State (2)
Stomach cancer (16)
Supply chain (83)
Tariffs (82)
The Weekly (81)
Vaccines (833)
Venture capital (61)
Weight loss (338)
Women's health (40)
Worklife (19)
Date
Last 7 days (455)
Last 30 days (1852)
Last 365 days (28644)
2025 (19807)
2024 (32553)
2023 (36674)
2022 (47341)
2021 (51153)
2020 (50698)
2019 (43988)
2018 (33374)
2017 (30409)
2016 (29474)
2015 (34063)
2014 (26138)
2013 (21726)
2012 (23117)
2011 (23986)
2010 (21481)
Location
Africa (827)
Alabama (52)
Alaska (6)
Arizona (190)
Arkansas (12)
Asia (42377)
Australia (7130)
California (7364)
Canada (2417)
China (821)
Colorado (324)
Connecticut (326)
Delaware (191)
Europe (86958)
Florida (1186)
Georgia (232)
Hawaii (1)
Idaho (55)
Illinois (629)
India (42)
Indiana (349)
Iowa (16)
Japan (253)
Kansas (104)
Kentucky (33)
Louisiana (18)
Maine (72)
Maryland (1039)
Massachusetts (5585)
Michigan (199)
Minnesota (410)
Mississippi (4)
Missouri (93)
Montana (28)
Nebraska (23)
Nevada (94)
New Hampshire (66)
New Jersey (2210)
New Mexico (30)
New York (2110)
North Carolina (1073)
North Dakota (8)
Northern California (3280)
Ohio (256)
Oklahoma (13)
Oregon (34)
Pennsylvania (1543)
Puerto Rico (18)
Rhode Island (31)
South America (1161)
South Carolina (42)
South Dakota (1)
Southern California (2848)
Tennessee (127)
Texas (1140)
United States (27609)
Utah (203)
Virginia (221)
Washington D.C. (77)
Washington State (652)
West Virginia (4)
Wisconsin (73)
626,217 Results for "cr pharma china resources pharmaceutical group limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
July 30, 2025
·
7 min read
Press Releases
Ascentage Pharma to Participate in Evercore China Biotech Summit
August 4, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Hengdian Group’s Apeloa Pharmaceutical uses Flow Chemistry for sustainable manufacturing
August 27, 2025
·
3 min read
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
If the trend holds, IQVIA expects 2025 deal volume between Chinese and multinational companies to easily eclipse the 100 agreements signed in 2024.
August 27, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
July 4, 2025
·
5 min read
Press Releases
Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair® Sublingual Immunotherapy Tablet for the Treatment of House Dust Mite Allergy in China
September 3, 2025
·
4 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
LSL PHARMA GROUP REPORTS THIRD CONSECUTIVE RECORD QUARTERLY REVENUES AND Q2 2025 FINANCIAL RESULTS
August 25, 2025
·
18 min read
Press Releases
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
June 16, 2025
·
2 min read
1 of 62,622
Next
